Reuters logo
WuXi Biologics set to open 21 pct higher in debut
June 13, 2017 / 1:34 AM / 5 months ago

WuXi Biologics set to open 21 pct higher in debut

HONG KONG, June 13 (Reuters) - Shares in WuXi Biologics (Cayman) Inc were set to open up 21.4 percent in their debut on Tuesday, as investors that couldn’t buy into the initial public offering jostled for a piece of the fast-growing business.

WuXi Biologics was indicated to open at HK$25, compared to its HK$20.60 IPO price. The benchmark Hang Seng index was poised to open 0.5 percent higher.

Reporting by Elzio Barreto; Additional reporting by Donny Kwok; Editing by Edwina Gibbs

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below